Osaic Holdings
ROIV icon

Osaic Holdings’s Roivant Sciences ROIV Stock Holding History

Osaic Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
6,844
-156
-2% -$4.61K ﹤0.01% 4268
2026
Q1 		$194K Sell
7,000
-49,978
-88% -$1.28M ﹤0.01% 4168
2025
Q4 		$1.24M Buy
56,978
+49,953
+711% +$986K ﹤0.01% 2493
2025
Q3 		$102K Buy
7,025
+1,242
+21% +$15.4K ﹤0.01% 4764
2025
Q2 		$65.1K Buy
5,783
+3,882
+204% +$42.1K ﹤0.01% 4848
2025
Q1 		$19.2K Sell
1,901
-9,441
-83% -$102K ﹤0.01% 5396
2024
Q4 		$134K Buy
11,342
+8,261
+268% +$97.7K ﹤0.01% 3962
2024
Q3 		$35.6K Buy
3,081
+919
+43% +$10.5K ﹤0.01% 4984
2024
Q2 		$22.9K Buy
2,162
+8
+0.4% +$88 ﹤0.01% 5253
2024
Q1 		$22.7K Buy
2,154
+2,122
+6,631% +$22.9K ﹤0.01% 5289
2023
Q4 		$359 Sell
32
-1,008
-97% -$9.82K ﹤0.01% 6942
2023
Q3 		$12.1K Buy
1,040
+553
+114% +$6.25K ﹤0.01% 5819
2023
Q2 		$4.91K Buy
487
+455
+1,422% +$4.07K ﹤0.01% 6323
2023
Q1 		$236 Buy
+32
New +$263 ﹤0.01% 7243
2022
Q1 		– Sell
-1,000
Closed -$10K – 7452
2021
Q4 		$10K Buy
+1,000
New +$8.32K ﹤0.01% 6256

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Osaic Holdings's ROIV Position: Q2 2026 in Review

Osaic Holdings reduced its Roivant Sciences (ROIV) stake by 2.2% in Q2 2026, selling an estimated $4.61K and leaving 6,844 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #4268.

Osaic Holdings first reported a position in ROIV in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.24M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Osaic Holdings held 6,844 shares of Roivant Sciences worth $242K as of Q2 2026.
  • Osaic Holdings sold 156 Roivant Sciences shares in Q2 2026, an estimated $4.61K.
  • Roivant Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4268 holding.
  • Osaic Holdings first reported a position in Roivant Sciences in Q4 2021 and has held it in 15 quarters since.
  • Osaic Holdings's Roivant Sciences position peaked at $1.24M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.